ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,485
Screening encounters
2,738
Diagnostic referrals
528
Outstanding pathways
217

Screening pathway

  1. Screening2,738Encounters
  2. Positive finding918Documented findings
  3. Referral528Diagnostic referrals
  4. Follow-up610Diagnostic visits
  5. Outcome311Resolved pathways

Stage totals use different units. Pending pathways: 217. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3601 · EXP-3601Synthetic · Site B

Full participant history through 2026-03-17, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-03-04
  4. · Diagnostic referral · EXP-3601-T-R
  5. · Contact attempt · Reached
  6. · Barrier documented · Appointment coordination
  7. · Diagnostic booking · Initial booking
  8. · Navigation intervention · Coordination support
  9. · Diagnostic visit · Attended
  10. · Diagnosis · Colposcopy · Biopsy collected
  11. · Diagnosis · Histopathology · High-grade lesion
  12. · Follow-up disposition · Resolved · EXP-3601-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2485 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3608 · Expanded synthetic participant 3608Site D — Community Engagement Programme
EXP-3610 · Expanded synthetic participant 3610Site D — Community Engagement Programme
EXP-3612 · Expanded synthetic participant 3612Site D — Community Engagement Programme
EXP-3614 · Expanded synthetic participant 3614Site B — Peri-Urban Access Programme
EXP-3615 · Expanded synthetic participant 3615Site C — Rural Outreach Programme
EXP-3620 · Expanded synthetic participant 3620Site B — Peri-Urban Access Programme
EXP-3621 · Expanded synthetic participant 3621Site A — Urban Referral Hub
EXP-3622 · Expanded synthetic participant 3622Site A — Urban Referral Hub
EXP-3624 · Expanded synthetic participant 3624Site E — Resource-Constrained Navigation Programme
EXP-3625 · Expanded synthetic participant 3625Site D — Community Engagement Programme
EXP-3626 · Expanded synthetic participant 3626Site D — Community Engagement Programme
EXP-3631 · Expanded synthetic participant 3631Site B — Peri-Urban Access Programme
EXP-3632 · Expanded synthetic participant 3632Site E — Resource-Constrained Navigation Programme
EXP-3633 · Expanded synthetic participant 3633Site A — Urban Referral Hub
EXP-3634 · Expanded synthetic participant 3634Site A — Urban Referral Hub
EXP-3637 · Expanded synthetic participant 3637Site D — Community Engagement Programme
EXP-3640 · Expanded synthetic participant 3640Site B — Peri-Urban Access Programme
EXP-3641 · Expanded synthetic participant 3641Site B — Peri-Urban Access Programme
EXP-3643 · Expanded synthetic participant 3643Site C — Rural Outreach Programme
EXP-3645 · Expanded synthetic participant 3645Site D — Community Engagement Programme
EXP-3646 · Expanded synthetic participant 3646Site C — Rural Outreach Programme
EXP-3649 · Expanded synthetic participant 3649Site B — Peri-Urban Access Programme
EXP-3652 · Expanded synthetic participant 3652Site A — Urban Referral Hub
EXP-3656 · Expanded synthetic participant 3656Site A — Urban Referral Hub
EXP-3661 · Expanded synthetic participant 3661Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1137
HPV DNA
1194
Cytology
407

Navigation activity

Barrier documented
449
Contact attempt
771
Navigation intervention
187
Diagnostic booking
647
Diagnostic visit
610

Documented barriers

Contact difficulty
142
Transport difficulty
143
Appointment coordination
164

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.